Lumida
/EDIT
⌘K
Editas Medicine Inc

Editas Medicine Inc

EDIT
$2.70USD↑+1.89%+0.05 today

MARKET CAP

414.7M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$3 – $3

52W RANGE

$2
$5

AI Summary

Stalk
StalkMedium

While the asset remains in a Stage 4 decline with a decisive support failure and lower-high/lower-low regime, mean-reversion conditions are present as near‐low forward P/E, elevated FCF yield, and price at a prior defended zone signal a potential counter‐trend opportunity. Short-term price is extended below declining EMAs without clear exhaustion, suggesting deferred entry. Execution should focus on stalking shallow pullbacks into the 9 EMA, 21 EMA, or the area just above the 200 DMA to participate in an anticipated mean-reversion.

  • ↑Renicel Ruby trial: all patients free from vaso-occlusive events post-infusion.
  • ↑Q2 2024 cash of $318M funds operations and R&D into 2026.
  • ↓Q1 2024 revenue dropped to $1.1M versus $9.9M in Q1 2023.
Full analysis →
Insider Trades36 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Aug 3, 2026SellEDITAmy ParisonSVP, Chief Financial Officer678$2.58$414.7M-40.49%+62.65%$1.7K-4.53%—Stalk
Jul 28, 2026SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER4,928$2.67$414.7M-40.49%+62.65%$13.2K-7.32%—Stalk
Jun 3, 2026SellEDITAmy ParisonSVP, Chief Financial Officer464$2.70$414.7M-40.49%+62.65%$1.3K-3.01%—Stalk
Jun 3, 2026SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER731$2.70$414.7M-40.49%+62.65%$2.0K-1.07%—Stalk
Jun 3, 2026SellEDITGilmore Neil O'NeillCEO15,380$2.70$414.7M-40.49%+62.65%$41.5K-5.83%—Stalk
Mar 3, 2026SellEDITAmy ParisonSVP, Chief Financial Officer474$2.02$414.7M-40.49%+62.65%$957.48-2.98%—Stalk
Mar 3, 2026SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER749$2.02$414.7M-40.49%+62.65%$1.5K-1.09%—Stalk
Mar 3, 2026SellEDITGilmore Neil O'NeillCEO5,394$2.02$414.7M-40.49%+62.65%$10.9K-2.00%—Stalk
Dec 3, 2025SellEDITAmy ParisonSVP, Chief Financial Officer461$2.15$414.7M-40.49%+62.65%$992.579-2.82%—Stalk
Dec 3, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER713$2.15$414.7M-40.49%+62.65%$1.5K-1.03%—Stalk
Dec 3, 2025SellEDITGilmore Neil O'NeillCEO5,603$2.15$414.7M-40.49%+62.65%$12.1K-2.04%—Stalk
Sep 3, 2025SellEDITAmy ParisonSVP, Chief Financial Officer458$2.60$414.7M-40.49%+62.65%$1.2K-2.72%—Stalk
Sep 3, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER710$2.60$414.7M-40.49%+62.65%$1.8K-1.01%—Stalk
Sep 3, 2025SellEDITGilmore Neil O'NeillCEO5,592$2.60$414.7M-40.49%+62.65%$14.5K-2.00%—Stalk
Aug 7, 2025SellEDITAmy ParisonSVP, Chief Financial Officer679$2.58$414.7M-40.49%+62.65%$1.8K-3.88%—Stalk
Jul 31, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER5,121$2.49$414.7M-40.49%+62.65%$12.8K-7.37%—Stalk
Jun 3, 2025SellEDITAmy ParisonSVP, Chief Financial Officer446$1.72$414.7M-40.49%+62.65%$768.904-2.48%—Stalk
Jun 3, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER726$1.72$414.7M-40.49%+62.65%$1.3K-1.03%—Stalk
Jun 3, 2025SellEDITGilmore Neil O'NeillCEO15,192$1.72$414.7M-40.49%+62.65%$26.2K-5.14%—Stalk
Mar 4, 2025SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER2,891$1.71$414.7M-40.49%+62.65%$4.9K-3.95%—Stalk
Mar 4, 2025SellEDITErick LuceraEVP, CHIEF FINANCIAL OFFICER4,109$1.71$414.7M-40.49%+62.65%$7.0K-3.52%—Stalk
Mar 4, 2025SellEDITGilmore Neil O'NeillCEO16,632$1.71$414.7M-40.49%+62.65%$28.5K-5.33%—Stalk
Dec 3, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER541$2.08$414.7M-40.49%+62.65%$1.1K-0.40%—Stalk
Dec 3, 2024SellEDITGilmore Neil O'NeillCEO1,618$2.08$414.7M-40.49%+62.65%$3.4K-0.52%—Stalk
Sep 4, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER518$3.42$414.7M-40.49%+62.65%$1.8K-0.39%—Stalk
Sep 4, 2024SellEDITGilmore Neil O'NeillCEO1,555$3.42$414.7M-40.49%+62.65%$5.3K-0.49%—Stalk
Jul 25, 2024SellEDITLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER11,886$5.42$414.7M-40.49%+62.65%$64.4K-13.98%—Stalk
Jul 19, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER6,619$5.21$414.7M-40.49%+62.65%$34.5K-4.69%—Stalk
Jun 4, 2024SellEDITBaisong MeiEVP, CHIEF MEDICAL OFFICER511$5.50$414.7M-40.49%+62.65%$2.8K-0.36%—Stalk
Jun 4, 2024SellEDITGilmore Neil O'NeillCEO12,191$5.50$414.7M-40.49%+62.65%$67.0K-3.72%—Stalk
May 20, 2024SellEDITErick LuceraEVP, CHIEF FINANCIAL OFFICER22,337$5.61$414.7M-40.49%+62.65%$125.4K-16.05%—Stalk
Mar 5, 2024SellEDITGilmore Neil O'NeillCEO77,824$9.42$414.7M-40.49%+62.65%$732.9K-9.76%—Stalk
Mar 4, 2024SellEDITBaisong MeiSVP, CHIEF MEDICAL OFFICER20,327$9.42$414.7M-40.49%+62.65%$191.4K-6.46%—Stalk
Dec 5, 2023SellEDITBruce EatonEVP, CBO AND CTO103$10.90$414.7M-40.49%+62.65%$1.1K-0.14%—Stalk
Nov 14, 2023SellEDITBruce EatonEVP, CBO AND CTO695$8.21$414.7M-40.49%+62.65%$5.7K-0.92%—Stalk
Nov 7, 2023SellEDITBruce EatonEVP, CBO AND CTO139$8.40$414.7M-40.49%+62.65%$1.2K-0.18%—Stalk